Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.15 USD | +1.59% | -7.43% | +22.76% |
Financials (USD)
Sales 2024 * | 270M | Sales 2025 * | 120M | Capitalization | 1.65B |
---|---|---|---|---|---|
Net income 2024 * | 77M | Net income 2025 * | 2M | EV / Sales 2024 * | 4.48 x |
Net cash position 2024 * | 442M | Net cash position 2025 * | 677M | EV / Sales 2025 * | 8.13 x |
P/E ratio 2024 * |
24.4
x | P/E ratio 2025 * |
-28.6
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | +1.59% | ||
1 week | -7.43% | ||
1 month | +12.11% | ||
3 months | -7.34% | ||
6 months | +54.59% | ||
Current year | +22.76% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 28.15 | +1.59% | 444,043 |
24-05-30 | 27.71 | -0.57% | 531,060 |
24-05-29 | 27.87 | -7.04% | 690,925 |
24-05-28 | 29.98 | -1.41% | 434,107 |
24-05-24 | 30.41 | -0.43% | 355,501 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.76% | 1.65B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- PTGX Stock